Nrf2 signaling and cell survival

Toxicology and Applied Pharmacology

Volumn 244, Issue 1, 2010, Pages 37-42

  Niture, Suryakant K ^a   Kaspar, James W ^a   Shen, Jun ^a   Jaiswal, Anil K ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cell signaling; Cell survival; Defensive gene expression; INrf2 (keap1); Nrf2; Oxidative electrophilic stress

Indexed keywords

GLUTATHIONE TRANSFERASE; GLYCOGEN SYNTHASE KINASE 3BETA; HEME OXYGENASE 1; KELCH LIKE ECH ASSOCIATED PROTEIN 1; PROTEIN KINASE C; PROTEIN KINASE FYN; PROTHYMOSIN ALPHA; SERINE; THIOREDOXIN; THREONINE; TRANSCRIPTION FACTOR NRF2; TYROSINE;

ANTIOXIDANT RESPONSIVE ELEMENT; AUTOREGULATION; CELL PROTECTION; CELL SURVIVAL; CYTOSOL; DOWNSTREAM PROCESSING; DRUG RESISTANCE; ELECTROPHILIC STRESS; ENZYME PHOSPHORYLATION; HUMAN; NUCLEAR EXPORT SIGNAL; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; ANTIOXIDANTS; BINDING SITES; CELL SURVIVAL; CYTOSKELETAL PROTEINS; DRUG RESISTANCE; HOMEOSTASIS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; NEOPLASMS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PHOSPHORYLATION; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION;

EID: 77649275857     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.06.009     Document Type: Review

References (99)

1. Albagli O., Dhordain P., Deweindt C., Lecocq G., and Leprince D. The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins. Cell Growth Differ. 6 (1995) 1193-1198
2. Ames B.N., Gold L.S., and Willett W.C. The causes and prevention of cancer. Proc. Natl. Acad. Sci. U.S.A 92 (1995) 5258-5265
3. Andrews N.C., Erdjument-Bromage H., Davidson M.B., Tempst P., and Orikin S.H. Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature 339 (1993) 722-727
4. Aoki Y., Sato H., Nishimura N., Takahashi S., Itoh K., and Yamamoto M. Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol. Appl. Pharm. 173 (2001) 154-160
5. Bauer C.E., Elsen S., and Bird T.H. Mechanisms for redox control of gene expression. Annu. Rev. Microbiol. 53 (1999) 495-523
6. Bloom D.A., and Jaiswal A.K. Phosphorylation of Nrf2 at Ser(40) by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J. Biol. Chem. 278 (2003) 44675-44682
7. Breen A.P., and Murphy J.A. Reactions of oxyl radicals with DNA. Free Radic. Biol. Med. 18 (1995) 1033-1077
8. Breimer L.H. Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: the role of DNA base damage. Mol. Carcinog. 3 (1990) 188-197
9. Buckley B.J., Marshall Z.M., and Whorton A.R. Nitric oxide stimulates Nrf2 nuclear translocation in vascular endothelium. Biochem. Biophys. Res. Commun 307 (2003) 973-979
10. Chan J.Y., Han X., and Kan Y.W. Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 11371-11375
11. Chan K., Lu R., Chang J.C., and Kan Y.W. NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 13943-13948
12. Chan J.Y., Kwong M., Lu R., Chang J., Wang B., Yen T.S., and Kan Y.W. Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice. EMBO J. 17 (1998) 1779-1787
13. Chan K., Han X.D., and Kan Y.W. An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 4611-4616
14. Choi A.M., and Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am. J. Respir. Cell Mol. Biol. 15 (1996) 9-19
15. Copple I.M., Goldring C.E., Kitteringham N.R., and Park B.K. The Nrf2-Keap1 defence pathway: role in protection against drug-induced toxicity. Toxicology 246 (2008) 24-33
16. Cullinan S.B., Zhang D., Hannik M., Arvisais E., Kaufman R.J., and Diehl J.A. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol. Cell. Biol. 23 (2003) 7198-7209
17. Cullinan S.B., Gordan J.D., Jin J., Harper J.W., and Diehl J.A. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol. Cell. Biol. 24 (2004) 8477-8486
18. De Long M.J., Santamaria A.B., and Talalay P. Role of cytochrome P1-450 in the induction of NAD(P)H:quinone reductase in a murine hepatoma cell line and its mutants. Carcinogenesis 8 (1987) 1549-1553
19. Dhakshinamoorthy S., and Jaiswal A.K. Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene. Oncogene 20 (2001) 3906-3917
20. Dhakshinamoorthy S., Long D.J., and Jaiswal A.K. Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens. Curr. Top. Cell. Regul. 36 (2000) 201-206
21. Dhakshinamoorthy S., Jain A.K., Bloom D.A., and Jaiswal A.K. Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants. J. Biol. Chem. 280 (2005) 16891-16900
22. Eggler A.L., Liu G., Pezzuto J.M., van Breemen R.B., and Mesecar A.D. Modifying specific cysteines of the electrophilie-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 10070-10075
23. Enomoto A., Itoh K., Nagayoshi E., Haruta J., Kimura T., O'Connor T., Harada T., and Yamamoto M. High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol. Sci. 59 (2001) 169-177
24. Giudice A., and Montella M. Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention. Bioessays 28 (2006) 169-181
25. Goetz M.E., and Luch A. Reactive species: a cell damaging rout assisting to chemical carcinogens. Cancer Lett. 266 (2008) 73-83
26. Grisham M.B., and McCord J.M. Chemistry and cytotoxicity of reactive oxygen metabolites. Physiology of Oxygen Radicals) (1986), Waverly Press, Baltimore 1-18
27. Halliwell B., and Gutteridge J.M.C. Free Radicals in Biology and Medicine. 4th ed. (2007), Oxford University Press
28. Hayashi A., Suzuki H., Itoh K., Yamamoto M., and Sugiyama Y. Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts. Biochem. Biophys. Res. Commun. 310 (2003) 824-829
29. Helen M., Dewald B., and Baggiolini M. Neutrophil signal transduction and activation of the respiratory burst. Physiol. Rev. 73 (1993) 797-821
30. Hu X., Roberts J.R., Apopa P.L., Kan Y.W., and Ma Q. Accelerated ovarian failure induced by 4-vinyl cyclohexene diepoxide in Nrf2-null mice. Mol. Cell. Biol. 26 (2006) 940-954
31. Huang H.C., Nguyen T., and Pickett C.B. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem. 277 (2002) 42769-42774
32. Igarashi K., Kataoka K., Nishizawa M., and Yamamoto M. Regulation of transcription of erythroid factor NF-E2 p45 with small Maf proteins. Nature 367 (1994) 568-572
33. Iida K., Itoh K., Kumagai Y., Oyasu R., Hattori K., Kawai K., Shimazui T., Akaza H., and Yamamoto M. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis. Cancer Res. 64 (2004) 6424-6431
34. Iizuka T., Ishii Y., Itoh K., Kiwamoto T., Kimura T., Matsuno Y., Morishima Y., Hegab A.E., Homma S., Nomura A., Sakamoto T., Shimura M., Yoshida A., Yamamoto M., and Sekizawa K. Nrf2 deficient mice are highly susceptible to cigarette smoke-induced emphysema. Genes Cells 10 (2005) 1113-1125
35. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh K., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., and Nabeshima Y. An Nrf2/small maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236 (1997) 313-322
36. Itoh K., Wakabayashi N., Katoh Y., ishii T., Igarashi K., Engel J.D., and Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes. Dev. 13 (1999) 76-86
37. Jain A.K., and Jaiswal A.K. Phosphorylation of tyrosine 568 controls nuclear export of Nrf2. J. Biol. Chem. 281 (2006) 12132-12142
38. Jain A.K., and Jaiswal A.K. GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J. Biol. Chem. 282 (2007) 16502-16510
39. Jain A.K., Bloom D.A., and Jaiswal A.K. Nuclear import and export signals in control of Nrf2. J. Biol. Chem. 280 (2005) 29158-29168
40. Jain A.K., Mahajan S., and Jaiswal A.K. Phosphorylation and dephosphorylation of tyrosine 141 regulate stability and degradation of INrf2: a novel mechanism in Nrf2 activation. J. Biol. Chem. 283 (2008) 17712-17720
41. Jaiswal A.K. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic. Biol. Med. 36 (2004) 1199-1207
42. Joseph P., and Jaiswal A.K. NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo(a)pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8413-8417
43. Kang M., Kobayashi A., Wakabayashi N., Kim S., and Yamamoto M. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 2046-2051
44. Kasprzak K.S. Possible role of oxidative damage in metal-induced carcinogenesis. Cancer Invest. 13 (1995) 411-430
45. Kerr M.E., Bender C.M., and Monti E.J. An introduction to oxygen free radicals. Heart Lung 25 (1996) 200-209
46. Kim I., Xu W., and Reed J.C. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat. Rev. Drug Dis. 7 (2008) 1013-1030
47. Kim I.F., Mohammadi E., and Huang R.C.C. Isolation and characterization of IPP, a novel human gene coding an actin-binding, KELCH-like protein. Gene 228 (1999) 73-83
48. Kim Y.J., Ahn J.Y., Liang P., Ip C., Zhang Y., and Park Y.M. Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology. Cancer Res. 67 (2007) 546-554
49. Kobayashi M., and Yamamoto M. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv. Enzyme Regul. 46 (2006) 113-140
50. Kobayashi A., Ito E., Toki T., Kogame K., Takahashi S., Igarashi K., Hayashi N., and Yamamoto M. Molecular cloning and functional characterization of a new cap'n'collar family transcription factor Nrf3. J. Biol. Chem. 274 (1999) 6443-6452
51. Kobayashi A., Kang M.I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., Igarashi K., and Yamamoto M. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 24 (2004) 7130-7139
52. Kretzschmar M., Reinhardt D., Schlechtweg J., Machnik G., Klinger W., and Schirrmeister W. Glutathione homeostasis in rats chronically treated with ethanol. Evidence for an increased hepatic GSH export in vivo. Exp. Toxicol. Pathol. 44 (1992) 344-348
53. Kwak M., Wakabayashi N., Itoh K., Motohashi H., Yamamoto M., and Kensler T.W. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway: identification of novel gene clusters for cell survival. J. Biol. Chem. 278 (2003) 8135-8145
54. Kwak M.K., Cho J.M., Huang B., Shin S., and Kensler T.W. Role of increased expression of the proteasome in the protective effects of sulforaphane against hydrogen peroxide-mediated cytotoxicity in murine neuroblastoma cells. Free Radic. Biol. Med. 43 (2007) 809-817
55. Last J.A., Sun W.M., and Witschi H. Ozone, NO, and NO2: oxidant air pollutants and more. Environ. Health Perspect. 102 Suppl. 10 (1994) 179-184
56. Lee O., Jain A.K., Papusha V., and Jaiswal A.K. An auto-regulatory loop between stress sensors INrf2 and Nrf2 controls their cellular abundance. J. Biol. Chem. 282 (2007) 36412-36420
57. Li Y., and Jaiswal A.K. Regulation of human NAD(P)H:quinone oxidoreductase gene: role of AP1 binding site contained within human antioxidant response element. J. Biol. Chem. 267 (1992) 15097-15104
58. Liu D., Chang J.C., Moi P., Liu W., Kan Y.W., and Curtin P.T. Dissection of the enhancer activity of beta-globin 5′ DNase I-hypersensitive site 2 in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 3899-3903
59. Maher J.M., Cheng X., Slitt A.L., Dieter M.Z., and Klaassen C.D. Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver. Drug Metab. Dispos. 33 (2005) 956-962
60. Maher J.M., Dieter M.Z., Aleksunes L.M., Slitt A.L., Guo G., Tanaka Y., Scheffer G.L., Chan J.Y., Manautou J.E., Chen Y., Dalton T.P., Yamamoto M., and Klaassen C.D. Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology 46 (2007) 1597-1610
61. Maher J., Aleksunes L., Dieter M., Tanaka Y., Peters J., Manautou J., and Klaassen C. Nrf2 and PPAR{alpha}-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid. Toxicol. Sci. 106 (2008) 319-328
62. Meneghini R. Iron homeostasis, oxidative stress, and DNA damage. Free Radic. Biol. Med. 23 (1997) 783-792
63. Mignotte V., Eleouet J.F., Raich N., and Romeo P.H. Cis- and trans-acting elements involved in the regulation of the erythroid promoter of the human porphobilinogen deaminase gene. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 6548-6552
64. Moi P., and Kan Y.W. Synergistic enhancement of globin gene expression by activator protein-1-like proteins. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 9000-9004
65. Moi P., Chan K., Asunis I., Cao A., and Kan Y.W. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2 like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of β-globin locus control region. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 9926-9930
66. Ney P.A., Sorrentino B.P., McDonaugh K.T., and Nienhuis A.W. Tandem AP-1-binding sites within the human beta-globin dominant control region function as an inducible enhancer in erythroid cells. Genes Dev. 4 (1990) 993-1006
67. Nioi P., and Nguyen T. A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity. Biochem. Biophys. Res. Commun. 362 (2007) 816-821
68. Niture, S.K., Jaiswal, A.K., 2009. Prothymosin-a mediates nuclear import of INrf2/Cul3-Rbx1 complex to degrade nuclear Nrf2. J. Biol. Chem. 284, 13856-13868.
69. Ohta T., Iijima K., Miyamoto M., Nakahara I., Tanaka H., Ohtsuji M., Suzuki T., Kobayashi A., Yokota J., Sakiyama T., Shibata T., Yamamoto M., and Hirohashi S. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res. 68 (2008) 1303-1309
70. Okawa H., Motohashi H., Kobayashi A., Aburatani H., Kensler T.W., and Yamamoto M. Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem. Biophys. Res. Commun. 339 (2006) 79-88
71. Okawa H., Motohashi H., Kobayashi A., Aburatani H., Kensler T.W., and Yamamoto M. Hepatocyte-specific deletion of the Keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem. Biophys. Res. Commun. 339 (2006) 79-88
72. Padmanabhan B., Tong K.I., Ohta T., Nakamura Y., Scharlock M., Ohtsuji M., Kang M.I., Kobayashi A., Yokoyama S., and Yamamoto M. Structural basis for defects of Keap1 activity provided by its point mutations in lung cancer. Mol. Cell 21 (2006) 689-734
73. Pickett C.B., and Lu A.Y.H. Glutathione S-transferases: gene structure, regulation and biological function. Ann. Rev. Biochem. 58 (1989) 743-764
74. Prestera T., Holtzclaw W.D., Zhang Y., and Talalay P. Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 2965-2969
75. Ramos-Gomez M., Kwak M.K., Dolan P.M., Itoh K., Yamamoto M., Talalay P., and Kensler T.W. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in Nrf2 transcription factor deficient mice. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 3410-3415
76. Rangasamy T., Guo J., Mitzner W.A., Roman J., Singh A., Fryer A.D., Yamamoto M., Kensler T.W., Tuder R.M., Georas S.N., and Biswal S. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J. Exp. Med. 202 (2005) 47-59
77. Rosen G.M., Pou S., Ramos C.L., Cohen M.S., and Britigan B.E. Free radicals and phagocytic cells. FASEB J. 9 (1995) 200-209
78. Shibata T., Kokubu A., Gotoh M., Ojima H., Ohta T., Yamamoto M., and Hirohashi S. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology 135 (2008) 1358-1368
79. Shibata T., Ohta T., Tong K.I., Kokubu A., Odogawa R., Tsuta K., Asamura H., Yamamoto M., and Hirohashi S. Cancer related mutations in Nrf2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 13568-13573
80. Shivdasani R., and Stuart H.O. Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 8690-8694
81. Singh A., Misra V., Thimmulappa R.K., Lee H., Ames S., Hoque M.O., Herman J.G., Baylin S.B., Sidransky D., Gabrielson E., Brock M.V., and Biswal S. Dysfunctional Keap1-Nrf2 interaction in non-small-cell lung cancer. PLos Med. 3 (2006) 1865-1876
82. Slitt A.L., Cherrington N.J., Dieter M.Z., Aleksunes L.M., Scheffer G.L., Huang W., Moore D.D., and Klaassen C.D. trans-Stilbene oxide induces expression of genes involved in metabolism and transport in mouse liver via CAR and Nrf2 transcription factors. Mol. Pharmacol. 69 (2006) 1554-1563
83. Suzuki Y.J., Forman H.J., and Sevanian A. Oxidants as stimulators of signal transduction. Free Radic. Biol. Med. 22 (1997) 269-285
84. Tsuchida S., and Sato K. Glutathione transferases and cancer. Crit. Rev. Biochem. Mol. Biol. 27 (1992) 337-384
85. Venugopal R., and Jaiswal A.K. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 14960-14965
86. Vollrath V., Wielandt A.M., Iruretagoyena M., and Chianale M. Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene. Biochem. J. 395 (2006) 599-609
87. Wakabayashi N., Itoh K., Wakabayashi J., Motohashi H., Noda S., Takahashi S., Imakado S., Kotsuji T., Otsuka F., Roop D.R., Harada T., Engel J.D., and Yamamoto M. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat. Genet. 35 (2003) 238-245
88. Wang X.J., Sun Z., Villeneuve N.F., Zhang S., Zhao F., Li Y., Chen W., Yi X., Zheng Y.X., Wondrack G.T., Wong P.K., and Zhang D.D. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29 (2008) 1235-1243
89. Ward J.F. The complexity of DNA damage: relevance to biological consequences. Int. J. Rad. Biol. 66 (1994) 427-432
90. Wasserman W., and Fahl W.E. Functional antioxidant responsive elements. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 5361-5366
91. Wei Y.H. Oxidative stress and mitochondrial DNA mutations in human aging. Proc. Soc. Exp. Biol. Med. 217 (1998) 53-63
92. Yu R., Mandlekar S., Weber M.J., Der C.J., Wu J., and Tony-Kong A.N. Role of mitogen-activated protein kinase pathway in the induction of phaseII detoxifying enzymes by chemicals. J. Biol. Chem. 274 (1999) 27545-27552
93. Zhang D.D. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab. Rev. 38 (2006) 769-789
94. Zhang D.D., and Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell. Biol. 23 (2003) 8137-8815
95. Zhang D.D., Lo S.C., Cross J.V., Templeton D.J., and Hannink M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell. Biol. 24 (2004) 10941-10953
96. Zhang D.D., Lo S., Sun Z., Habib G.M., Lieberman M.W., and Hannink M. Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway. J. Biol. Chem. 280 (2005) 30091-30099
97. Zheng M., and Storz G. Redox sensing by prokaryotic transcription factors. Biochem. Pharm. 59 (2000) 1-6
98. Zipper L.M., and Mulcahy R.T. Inhibition of ERK and p38 MAP kinases inhibits binding of Nrf2 and induction of GCS genes. Biochem. Biophys. Res. Commun. 278 (2000) 484-492
99. Zipper L.M., and Mulcahy R.T. The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm. J. Biol. Chem. 277 (2002) 36544-36552